Agenus Announces Three BOT+BAL Presentations Spanning Neoadjuvant and Late-Line Colorectal Cancer and Advanced Sarcomas at ESMO 2026
Go back to Agenus Announces Three BOT+BAL Presentations Spanning Neoadjuvant and Late-Line Colorectal Cancer and Advanced Sarcomas at ESMO 2026| AGENUS (NASDAQ: AGEN) | Delayed: 6.19 +0.66 (11.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.53 | 52 Week High | $7.49 | |||
| Open | $5.53 | 52 Week Low | $2.61 | |||
| Day High | $6.23 | P/E | N/A | |||
| Day Low | $5.46 | EPS | $-1.10 | |||
| Volume | 2,332,499 | |||||

